Symptomtext
during administration of Shingrix half of the dose leaked out of the needle; during administration of Shingrix half of the dose leaked out of the needle and down the patients arm; during administration of Shingrix half of the dose leaked out of the needle and down the patients arm; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number 2Z9N3, expiry date 26-SEP-2025) for prophylaxis. On 27-SEP-2023, the patient received Shingrix. On 27-SEP-2023, an unknown time after receiving Shingrix, the patient experienced accidental underdose (Verbatim: during administration of Shingrix half of the dose leaked out of the needle), exposure via skin contact (Verbatim: during administration of Shingrix half of the dose leaked out of the needle and down the patients arm) and inadvertent exposure to vaccine (Verbatim: during administration of Shingrix half of the dose leaked out of the needle and down the patients arm). The outcome of the accidental underdose, exposure via skin contact and inadvertent exposure to vaccine were unknown. Additional Information: GSK Receipt Date: 28-SEP-2023 Pharmacist reports during administration of Shingrix half of the dose leaked out of the needle and down the patients arm, which led to accidental underdose, exposure via skin contact and inadvertent exposure to vaccine. The reporter consented to follow up.